New diabetes clinical trial: A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Published on: February 12, 2024 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: GZR18; Other: Placebo
Sponsors: Gan and Lee Pharmaceuticals, USA
Completed
https://ift.tt/96xqcKg